7h ), but the content of MHCII showed a trend towards a decrease in pioglitazone-treated mice compared to untreated Cox10 /DAT-cre animals (Fig. 7h ).
← all excerpts
Pioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammation.
1
—
—